Il-27 and tgfb mediated expansion of th1 and adaptive regulatory t cells expressing il-10 correlates with bacterial burden and disease severity in pulmonary tuberculosis

Immunity, Inflammation and Disease

Volumn 3, Issue 3, 2015, Pages 289-299

  Kumar, Nathella P ^a   Moideen, Kadar ^a   Banurekha, Vaithilingam V ^b   Nair, Dina ^b   Sridhar, Rathinam ^c   Nutman, Thomas B ^d   Babu, Subash ^a,d  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE FOR RESEARCH IN TUBERCULOSIS   (India)

^c Government Stanley Hospital   (India)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Cytokines; IL 10; Regulation; T cells; Tuberculosis

Indexed keywords

EID: 85011717489     PISSN: None     EISSN: 20504527     Source Type: Journal    
DOI: 10.1002/iid3.68     Document Type: Article

References (37)

1. Moore, K. W., R. de Waal Malefyt, R. L. Coffman, and A. O’Garra. 2001. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19:683–765.
2. Saraiva, M., and A. O’Garra. 2010. The regulation of IL-10 production by immune cells. Nat. Rev. Immunol. 10: 170–181.
3. Gabrysova, L., A. Howes, M. Saraiva, and A. O’Garra. 2014. The regulation of IL-10 expression. Curr. Top Microbiol. Immunol. 380:157–190.
4. Ouyang, W., S. Rutz, N. K. Crellin, P. A. Valdez, and S. G. Hymowitz. 2011. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu. Rev. Immunol. 29:71–109.
5. Couper, K. N., D. G. Blount, and E. M. Riley. 2008. IL-10: the master regulator of immunity to infection. J. Immunol. 180:5771–5777.
6. + effector T cells: a mechanism for self-regulation. Mucosal. Immunol. 3:239–246.
7. Zhu, J., and W. E. Paul. 2008. CD4 T cells: fates, functions, and faults. Blood 112:1557–1569.
8. Maizels, R. M., and K. A. Smith. 2011. Regulatory T cells in infection. Adv. Immunol. 112:73–136.
9. O’Garra, A., P. S. Redford, F. W. McNab, C. I. Bloom, R. J. Wilkinson, and M. P. Berry. 2013. The immune response in tuberculosis. Annu. Rev. Immunol. 31:475–527.
10. O’Leary, S., M. P. O’Sullivan, and J. Keane. 2011. IL-10 blocks phagosome maturation in mycobacterium tuberculosis-infected human macrophages. Am. J. Respir. Cell Mol. Biol. 45:172–180.
11. Schreiber, T., S. Ehlers, L. Heitmann, A. Rausch, J. Mages, P. J. Murray, R. Lang, and C. Holscher. 2009. Autocrine IL-10 induces hallmarks of alternative activation in macrophages and suppresses antituberculosis effector mechanisms without compromising T cell immunity. J. Immunol. 183:1301–1312.
12. Demangel, C., P. Bertolino, and W. J. Britton. 2002. Autocrine IL-10 impairs dendritic cell (DC)-derived immune responses to mycobacterial infection by suppressing DC trafficking to draining lymph nodes and local IL-12 production. Eur. J. Immunol. 32:994–1002.
13. Fiorentino, D. F., A. Zlotnik, P. Vieira, T. R. Mosmann, M. Howard, K. W. Moore, and A. O’Garra. 1991. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J. Immunol. 146:3444–3451.
14. Kumar, N. P., V. Gopinath, R. Sridhar, L. E. Hanna, V. V. Banurekha, M. S. Jawahar, T. B. Nutman, and S. Babu. 2013. IL-10 dependent suppression of type 1, type 2 and type 17 cytokines in active pulmonary tuberculosis. PLoS ONE 8: e59572.
15. Pitt, J. M., E. Stavropoulos, P. S. Redford, A. M. Beebe, G. J. Bancroft, D. B. Young, and A. O’Garra. 2012. Blockade of IL-10 signaling during bacillus Calmette-Guerin vaccination enhances and sustains Th1, Th17, and innate lymphoid IFN-gamma and IL-17 responses and increases protection to Mycobacterium tuberculosis infection. J. Immunol. 189:4079–4087.
16. Boussiotis, V. A., E. Y. Tsai, E. J. Yunis, S. Thim, J. C. Delgado, C. C. Dascher, A. Berezovskaya, D. Rousset, J. M. Reynes, and A. E. Goldfeld. 2000. IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. J. Clin. Invest. 105:1317–1325.
17. Stumhofer, J. S., J. S. Silver, A. Laurence, P. M. Porrett, T. H. Harris, L. A. Turka, M. Ernst, C. J. Saris, J. J. O’Shea, and C. A. Hunter. 2007. Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat. Immunol. 8: 1363–1371.
18. Xu, J., Y. Yang, G. Qiu, G. Lal, Z. Wu, D. E. Levy, J. C. Ochando, J. S. Bromberg, and Y. Ding. 2009. C-Maf regulates IL-10 expression during Th17 polarization. J. Immunol. 182:6226–6236.
19. Alegre, M. L., H. Shiels, C. B. Thompson, and T. F. Gajewski. 1998. Expression and function of CTLA-4 in Th1 and Th2 cells. J. Immunol. 161:3347–3356.
20. Brown, J. A., D. M. Dorfman, F. R. Ma, E. L. Sullivan, O. Munoz, C. R. Wood, E. A. Greenfield, and G. J. Freeman. 2003. Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production. J. Immunol. 170:1257–1266.
21. Metenou, S., B. Dembele, S. Konate, H. Dolo, S. Y. Coulibaly, Y. I. Coulibaly, A. A. Diallo, L. Soumaoro, M. E. Coulibaly, D. Sanogo, et al. 2010. At homeostasis filarial infections have expanded adaptive T regulatory but not classical Th2 cells. J. Immunol. 184:5375–5382.
22. + (Foxp3) regulatory T cells in human visceral leishmaniasis. J. Exp. Med. 204:805–817.
23. Jagannathan, P., I. Eccles-James, K. Bowen, F. Nankya, A. Auma, S. Wamala, C. Ebusu, M. K. Muhindo, E. Arinaitwe, J. Briggs, et al. 2014. IFNgamma/IL-10 co-producing cells dominate the CD4 response to malaria in highly exposed children. PLoS Pathog. 10:e1003864.
24. Jankovic, D., M. C. Kullberg, C. G. Feng, R. S. Goldszmid, C. M. Collazo, M. Wilson, T. A. Wynn, M. Kamanaka, R. A. Flavell, and A. Sher. 2007. Conventional T-bet(+) Foxp3( ) Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection. J. Exp. Med. 204:273–283.
25. Anderson, C. F., M. Oukka, V. J. Kuchroo, and D. Sacks. 2007. CD4(+)CD25( ) Foxp3( ) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis. J. Exp. Med. 204:285–297.
26. Licona-Limon, P., J. Henao-Mejia, A. U. Temann, N. Gagliani, I. Licona-Limon, H. Ishigame, L. Hao, D. R. Herbert, and R. A. Flavell. 2013. Th9 cells drive host immunity against gastrointestinal worm infection. Immunity 39:744–757.
27. Zielinski, C. E., F. Mele, D. Aschenbrenner, D. Jarrossay, F. Ronchi, M. Gattorno, S. Monticelli, A. Lanzavecchia, and F. Sallusto. 2012. Pathogen-induced human TH17 cells produce IFN-gamma or IL-10 and are regulated by IL-1beta. Nature 484:514–518.
28. + regulatory T cells control Leishmania major persistence and immunity. Nature 420:502–507.
29. Redford, P. S., P. J. Murray, and A. O’Garra. 2011. The role of IL-10 in immune regulation during M. tuberculosis infection. Mucosal. Immunol. 4:261–270.
30. Sallusto, F., C. E. Zielinski, and A. Lanzavecchia. 2012. Human Th17 subsets. Eur. J. Immunol. 42:2215–2220.
31. Saraiva, M., J. R. Christensen, M. Veldhoen, T. L. Murphy, K. M. Murphy, and O’Garra A. 2009. Interleukin-10 production by Th1 cells requires interleukin-12-induced STAT4 transcription factor and ERK MAP kinase activation by high antigen dose. Immunity 31:209–219.
32. + T cells and monocytes. Blood 87:4731–4736.
33. Rutz, S., M. Janke, N. Kassner, T. Hohnstein, M. Krueger, and A. Scheffold. 2008. Notch regulates IL-10 production by T helper 1 cells. Proc. Natl. Acad. Sci. USA. 105:3497–3502.
34. Neumann, C., F. Heinrich, K. Neumann, V. Junghans, M. F. Mashreghi, J. Ahlers, M. Janke, C. Rudolph, N. Mockel-Tenbrinck, A. A. Kuhl, et al. 2014. Role of Blimp-1 in programing Th effector cells into IL-10 producers. J. Exp. Med. 211:1807–1819.
35. Parish, I. A., H. D. Marshall, M. M. Staron, P. A. Lang, A. Brustle, J. H. Chen, W. Cui, Y. C. Tsui, C. Perry, B. J. Laidlaw, et al. 2014. Chronic viral infection promotes sustained Th1-derived immunoregulatory IL-10 via BLIMP-1. J. Clin. Invest. 124:3455–3468.
36. Jurado, J. O., I. B. Alvarez, V. Pasquinelli, G. J. Martinez, M. F. Quiroga, E. Abbate, R. M. Musella, H. E. Chuluyan, and V. E. Garcia. 2008. Programmed death (PD)-1:PD-ligand 1/PD-ligand 2 pathway inhibits T cell effector functions during human tuberculosis. J. Immunol. 181:116–125.
37. Kirman, J., K. McCoy, S. Hook, M. Prout, B. Delahunt, I. Orme, A. Frank, and G. Le Gros. 1999. CTLA-4 blockade enhances the immune response induced by mycobacterial infection but does not lead to increased protection. Infect. Immun. 67:3786–3792.